Finished product reference
Dextromethorphan / Guaifenesin / Phenylephrine
Syrup · Oral · 10 mg/100 mg/5 mg/5mL · 200 mL
- List code
- 52877
- Pharmacologic class
- Expectorant
Indications
Uses • Helps loosen phlegm (mucus) and thin bronchial secretions to drain bronchial tubes • Temporarily relieves these symptoms occurring with a cold: • nasal congestion • cough due to minor throat and bronchial irritation.
Dosage and administration (summary)
Directions • do not take more than 4 doses in any 24-hour period. AGE DOSE Adults and Children 12 years of age and over Take 1 teaspoonfuls (5 mL) every 6 hours Children under 12 years of age ask a doctor
Warnings and precautions
Warnings Do not use if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.
Storage and supply
Other information • Tamper Evident Feature: Do not use if safety seal is torn, cut or opened. • Store at controlled room temperature 15° - 30ºC (59º - 86ºF). • Avoid excessive heat or humidity.
Source: Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride (Actidom Dmx) — US FDA prescribing information, 2024-06-28, DailyMed. Summarised and shortened; the full label governs. Iranian registration, indications and labelling may differ.
Other presentations of the same active ingredient
Reference information for professional sourcing and registration enquiries, not medical advice or a promotion. Drug information is condensed from US FDA prescribing information (public domain, via openFDA and DailyMed) and does not replace the product’s approved labelling in Iran. Availability, origin and documentation are confirmed per enquiry.
Tell us the quantity, the market and the timing.
Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.